Biological response modifiers in renal cancer
Ackermann, R.
Progress in Clinical and Biological Research 269: 313-328
1988
ISSN/ISBN: 0361-7742 PMID: 2455907 Document Number: 313576
Document emailed within 1 workday
Related Documents
Muss, H.B. 1988: The role of biological response modifiers in metastatic renal cell carcinoma Seminars in Oncology 15(5 Suppl 5: 30-34Okawa, T.; Goto, M.; Kita, M. 1987: Radiotherapy combined with BRM (biological response modifiers) in the treatment of cancer Gan no Rinsho. Japan Journal of Cancer Clinics 33(10): 1253-1256
Ishihara, K. 1989: On the behalf of the Japanese Society of Biological Response Modifiers Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Pt 2-1): 906-911
Kirkpatrick, C.H. 1989: Biological response modifiers. Interferons, interleukins, and transfer factor Annals of Allergy 62(3): 170-176
Zlotta, A.R.; Schulman, C.C. 2000: Biological response modifiers for the treatment of superficial bladder tumors European Urology 37(Suppl): 10-15
Scheinberg, M.A. 1988: Clinical trials with biological response modifiers in rheumatic diseases Journal of Rheumatology 15(7): 1056-1057
Saito, A. 2001: A putative immunotherapy with biological response modifiers (BRM) against intractable pulmonary tuberculosis Kekkaku: 76(12): 741-747
Irwin, M.M. 1987: Patients receiving biological response modifiers: overview of nursing care Oncology Nursing Forum 14(6 Suppl): 32-37
Koga, H.; Miyazaki, Y.; Kohno, S.; Hara, K. 1994: A drug delivery system and biological response modifiers for the treatment of mycobacterial infection Kekkaku: 69(2): 113-118
Bergmann, L. 1989: Malignant melanoma--prognosis and actual treatment strategies with chemotherapy and biological response modifiers European Journal of Cancer and Clinical Oncology 25(Suppl 3): S31-S36
Talmadge, J.E.; Herberman, R.B. 1986: The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers Cancer Treatment Reports 70(1): 171-182
Quesada, J.R. 1988: Biologic response modifiers in the therapy of metastatic renal cell carcinoma Seminars in Oncology 15(4): 396-407
Quesada, J.R. 1989: Biologic response modifiers in cancer therapy: a review Texas Medicine 85(11): 42-47
Nio, Y.; Zighelboim, J.; Berek, J.S.; Bonavida, B. 1990: Augmentation of cytotoxicity of lymphokine activated killer cells on ovarian tumor cells by various biological response modifiers Anticancer Research 10(2a): 441-446
Sodhi, A.; Pai, K. 1992: Studies on the release of interleukin-1 (IL-1), tumor necrosis factor (TNF) and lysozyme from human non-adherent mononuclear cells (nMNC) in vitro after treatment with cisplatin and other biological response modifiers Neoplasma 39(4): 211-217
Pawłowska, M.łg. 2005: HCV: immune response and its modifiers in clinical development Przeglad Epidemiologiczny 59(2): 519-523
Markenson, J. 2007: Safety and efficacy of the biologic response modifiers American Journal of Orthopedics 36(3 Suppl): 15-19
Novak, M.J.; Donley, T.G. 2002: Using host response modifiers in the treatment of periodontal disease Practical Procedures and Aesthetic Dentistry: Ppad 14(9): Suppl 3
Borden, E.C.; Hawkins, M.J. 1986: Biologic response modifiers as adjuncts to other therapeutic modalities Seminars in Oncology 13(2): 144-152
Yokota, S. 2007: Biologic response modifiers for juvenile idiopathic arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 65(7): 1331-1335